SELVAS Healthcare, Inc. (KOSDAQ:208370)

SELVAS Healthcare Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	30,193	30,825	31,702	29,813	27,686	29,089
Revenue Growth	-6.09%	-2.77%	6.34%	7.68%	-4.83%	37.52%
Gross Profit Gross Profit Growth	14,519	14,998	16,561	15,650	13,985	13,853
Operating Income Operating Income Growth	157.96	-161.56	3,275	3,349	2,486	3,416
Net Income Net Income Growth	16,918	3,889	3,152	5,170	2,813	2,472
Earnings Per Share EPS Growth	645.99	150.72	122.00	214.00	94.38	114.00
EPS Growth	510.18%	23.54%	-42.99%	126.75%	-17.21%	225.71%

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	38,892	26,376	26,089	24,280	7,061	14,872
Total Debt Total Debt Growth	1,425	1,725	2,996	3,239	7,833	16,753
Net Cash (Debt) Net Cash Growth	37,466	24,652	23,092	21,041	-771.46	-1,881
Net Cash Growth	88.58%	6.75%	9.75%	-	-	-
Net Cash Per Share Net Cash Per Share Growth	1430.04	955.37	893.83	870.30	-32.65	-86.85

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	2,207	304.75	4,500	3,472	50.81	2,928
Capital Expenditures CapEx Growth	-1,142	-856.8	-716.31	-359.64	-352.31	-371.2
Free Cash Flow Free Cash Flow Growth	1,065	-552.04	3,783	3,112	-301.51	2,557
Free Cash Flow Growth	-74.47%	-	21.57%	-	-	-37.46%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	48.09%	48.66%	52.24%	52.50%	50.51%	47.62%
Operating Margin	0.52%	-0.52%	10.33%	11.23%	8.98%	11.74%
Pretax Margin	59.22%	15.74%	10.41%	12.94%	10.30%	8.72%
Profit Margin	56.03%	12.62%	9.94%	17.34%	10.16%	8.50%
FCF Margin	3.53%	-1.79%	11.93%	10.44%	-1.09%	8.79%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	4.15	38.42	33.09	33.90	16.09	26.29
Forward PE	-	20.30	20.30	20.30	20.30	20.30
P/FCF Ratio	64.72	-	27.56	56.31	-	25.41
PS Ratio	2.28	4.85	3.29	5.88	1.64	2.23

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error